Requests for authorisation of conferences and meetings |
Italian Medicines Agency
Aifa toggle bar Search
Search keywords
The Agency
The Agency
Mission and values
Organisation
Scientific and Economic Committee for Medicines
Support and Coordination Secretariats and Advisory Committees
International Collaborations
EU Projects
Legislation
Forms
Competition notices
Resolutions
Tenders and contracts
Quality assurance
Guarantee Committee
Atti di notifica
Associazioni dei pazienti
AIFA Incontra
Contacts
Certified email
COVID-19
COVID-19
Communications about COVID-19
COVID-19 Vaccines
Medicines usable for treatment of COVID-19 disease
Use of monoclonal antibodies for COVID-19
Use of antivirals for COVID-19
Monitoring of medicinal products used during the COVID-19 epidemic
Clinical Trials - COVID-19
Compassionate Use Programs - COVID-19
Access to medicinal products
Access to medicinal products
Early access and off-label use
Authorisation of medicinal products
Medicine shortages
Antibiotic medicinal products
Biological medicinal products
Vaccines
Blood derivatives
Generic medicinal products
Biosimilar medicinal products
Orphan medicinal products
Advanced therapies
Homeopathic medicinal products
Allergens
Medicinali di origine vegetale
Ancillary medicinal substances incorporated in medical devices
Safety of medicinal products
Safety of medicinal products
Pharmacovigilance
National Pharmacovigilance Network
Adverse Reactions to medicinal products
Persons in charge of Pharmacovigilance
European Eudravigilance System
Accesso alle segnalazioni - ADRreports
Regional pharmacovigilance funds
Segnali di sicurezza
Risk management measures
Medicinal products subject to additional monitoring
Quality and Inspections
Quality and Inspections
Quality defects
Inspections and authorisations
Qualified person
Fight of pharmaceutical crime
Research and Clinical trials
Research and Clinical trials
Clinical trials concerning medicinal products
EU Regulation on Clinical trials
National Observatory on Clinical Trials
Registro Studi Osservazionali
Comitati Etici Nazionali (CEN)
Ethics Committees Coordination Centre
Independent clinical research
Mappa dei centri di Sperimentazione Clinica
Pricing and reimbursement
Pricing and reimbursement
Negotiation and reimbursement
Economic evaluations
Monitoring Registers
AIFA Notes
Lists of Class A and Class H medicinal products
Innovative medicinal products
Transparency Lists
Consumption and pharmaceutical expenditure
Consumption and pharmaceutical expenditure
The Medicines Utilization Monitoring Centre (OsMed)
Governance of pharmaceutical expenditure
Monitoring pharmaceutical expenditure
Innovation and planning
Innovation and planning
Innovation and scientific advice
Horizon scanning
Information and communication
Information and communication
FarmaciLine
Medical and scientific information
FAQ
Publications
Communication campaigns
Eventi AIFA
Scientific Seminars
Press releases
Dossier AIFA
Mobile APP AIFA
APP Firstline AIFA - Antibiotici
ABC della Ricerca Clinica
Presentations and speeches
Public consultations and documents
Documents shared with scientific communities
Calendario eventi
Archivio
AIFA data
AIFA data
OsMed Data
Open Data
Companies Section
Companies Section
Requests for authorisation of conferences and meetings
Payment of fees and annual duties
MA Electronic invoicing
Application for reimbursement and pricing
Access information
Notifica concessionari di vendita
Comunicazione prima commercializzazione
Open governance
Open governance
Disposizioni Generali
Organizzazione
Consulenti e collaboratori
Personale
Bandi di Concorso
Performance
Enti controllati
Attività e procedimenti
Provvedimenti
Bandi di gara e contratti
Sovvenzioni, contributi, sussidi, vantaggi economici
Bilanci
Beni immobili e gestione patrimonio
Controlli e rilievi sull'Amministrazione
Servizi Erogati
Pagamenti dell'Amministrazione
Opere pubbliche
Pianificazione e governo del territorio
Informazioni ambientali
Interventi straordinari di emergenza
Altri Contenuti
Requests for authorisation of conferences and meetings
Authorisation for Conferences and Meetings
Any Italian or foreign pharmaceutical company which is the owner of medicines with marketing authorisation in Italy (AIC), or which on the basis of an agreement with the respective owner provides for the actual marketing of medicines, and which intends to organise or contribute to the organisation of a congress, conference or meeting on issues related to the use of medicines, must send to the Italian Medicines Agency a communication authorising the proposed educational meetings in order to allow the Agency to verify their strict technical nature, pursuant to Article 124 of Legislative Decree 219/2006.
Starting from 2 April 2024, it is no longer possible to use the InfoCamere portal and all communications relating to conferences and meetings have to be transmitted exclusively via the new version of the online service "Authorisation for Conferences and Meetings NEW".
FAQ autorizzazione convegni e congressi
Domande e risposte su autorizzazione convegni e congressi (valide dal 24 settembre 2025) >
News List
Nuove funzionalità del sistema Autorizzazione Convegni e Congressi (14/01/2026)
Nuove Funzionalità del Sistema Autorizzazione Convegni e Congressi (30/09/2025)
Autorizzazione Convegni e Congressi - chiarimenti su "Consuntivazione eventi conclusi" (17/02/2025)
Autorizzazione Convegni e Congressi - Consuntivazione eventi conclusi (13/02/2025)
Nuovo applicativo Autorizzazione Convegni e Congressi - Interventi evolutivi (29/11/2024)
Autorizzazione Convegni e Congressi: consuntivazione eventi conclusi
Authorisation for Conferences and Meetings: release of new functions (17/07/2024)
New procedures for authorisation of conferences and meetings concerning human medicinal products (08/03/2024)
Online services
How to access to “Autorizzazione Convegni e Congressi New”
How to access AIFA IT systems
How to pay the stamp duty (03/04/2020)
Access to fee payment system
Information for organisers
Information for organisers
In the case of events in which more than one pharmaceutical company participates (conferences, congresses or meetings to which more than one pharmaceutical company contributes), notifications must be sent jointly, through an Organiser.
Starting from 2 April 2024, the pre-application must be entered by the organisers exclusively through the new version "Authorisation for Conferences and Meetings NEW" available on AIFA's online services.
Data entry takes place in three subsequent steps:
Entry of conference/meeting data
Entry of participating companies
Entry single file
Subsequently, the pharmaceutical companies participating in the event complete and submit their requests through the online service “Authorisation for Conferences and Meetings” in accordance with the provisions of Article 124 of Legislative Decree no. 219 of 24 April 2006.
Information for pharmaceutical companies
Events in which only one pharmaceutical company participates must be communicated to AIFA, by the ACC contact person with a digital signature, through the online service "Authorisation for conferences and meetings".
Companies which contribute with other pharmaceutical companies to the same event must complete the applications, already entered by the organisers, through the online service "Authorisation for conferences and meetings" within the 60 days provided for in paragraph 1, article 124, of legislative decree no. 219 of 24 April 2006.
Please note that for each event, the company is required to pay the fee corresponding to the estimated charge according to the Decree of the Minister of Health of 6 December 2016.
For further clarifications and information regarding the procedure and payment of the fees, please contact the competent accounting and budget office at
integraconvcong@aifa.gov.it.
For details on how to access and use the online service Authorisation for conferences and meetings please refer to the available manuals.
Malfunctions related to the online service Authorisation for conferences and meetings must be reported to the AIFA IT helpdesk.
Regulations concerning the authorisation of conferences and meetings
Legislative Decree no. 219 of 24 April 2006
Law no. 326 of 2003
Ministerial Decree 06/12/2016 “Updating of existing fees and pricing of not-yet-charged services”
List of current fees
Notice on conferences and meetings pursuant to art.124, Law Decree 219/06 dated 11 February 2010
Directive 2001/83/EC of the European Parliament and of the Council
Commission Directive 2003/94/EC
Companies Section
Requests for authorisation of conferences and meetings
FAQs on requests for authorisation of conferences and meetings
Payment of fees and annual duties
MA Electronic invoicing
Application for reimbursement and pricing
Access information
Notifica concessionari di vendita
Comunicazione prima commercializzazione
Share
Guides
Guide for pharmaceutical companies [2.48 Mb] [PDF] >
Guida rapida primo accesso Segreteria Organizzativa (08/03/2024) [1.09 Mb] [PDF] >
Manuale d'uso Impresa Farmaceutica (08/03/2024) [3.04 Mb] [PDF] >
Manuale d'uso delle aziende farmaceutiche [2.48 Mb] [PDF] >
Cookie Bar
Footer
The agency
Home Page
FarmaciLine
User participation and satisfaction
Citizens' access
Modulistica
Open governance
Acts of notification
Legal notification
TrovaNormeFarmaco
Competition notices
Tenders and contracts
Contacts
Via del Tritone, 181 00187 Roma
Contacts
Certified e-mail (PEC) contacts
VAT number: 08703841000
Tax code: 97345810580
IPA AIFA code: aifa_rm
IPA UCB code: UFE1TR
FOLLOW US ON
label.button.spotify
Bluesky
FEED RSS
Feed Rss
Cookie management
Sezione Link Utili
Legal notice
Social Media Policy
Dichiarazione di accessibilità
Web accessibility
Website statistics
Online services
go to beginning of content